| Year |
Citation |
Score |
| 2018 |
Fillmore CM, Xu C, Desai PT, Berry JM, Rowbotham SP, Lin YJ, Zhang H, Marquez VE, Hammerman PS, Wong KK, Kim CF. Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. PMID 30250255 DOI: 10.1038/S41586-018-0580-6 |
0.314 |
|
| 2016 |
Zhang H, Qi J, Reyes JM, Li L, Rao PK, Li F, Lin CY, Perry JA, Lawlor MA, Federation A, De Raedt T, Li YY, Liu Y, Duarte MA, Zhang Y, ... ... Fillmore CM, et al. Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer. Cancer Discovery. PMID 27312177 DOI: 10.1158/2159-8290.Cd-16-0164 |
0.487 |
|
| 2016 |
Fillmore CM, Xu C, Sánchez-Rivera FJ, Jacks T, Wong K, Kim CF. Using stem cell biology to design precision medicine for non-small cell lung cancer Journal of Thoracic Oncology. 11. DOI: 10.1016/J.Jtho.2015.12.006 |
0.533 |
|
| 2015 |
Fillmore CM, Xu C, Desai PT, Berry JM, Rowbotham SP, Lin YJ, Zhang H, Marquez VE, Hammerman PS, Wong KK, Kim CF. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. 520: 239-42. PMID 25629630 DOI: 10.1038/Nature14122 |
0.389 |
|
| 2015 |
Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: A heterogeneous set of diseases (Nature Reviews Cancer (2014) 14 (535-546)) Nature Reviews Cancer. 15: 247. DOI: 10.1038/Nrc3931 |
0.47 |
|
| 2014 |
Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nature Reviews. Cancer. 14: 535-46. PMID 25056707 DOI: 10.1038/Nrc3775 |
0.489 |
|
| 2014 |
Sinkevicius KW, Kriegel C, Bellaria KJ, Lee J, Lau AN, Leeman KT, Zhou P, Beede AM, Fillmore CM, Caswell D, Barrios J, Wong KK, Sholl LM, Schlaeger TM, Bronson RT, et al. Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proceedings of the National Academy of Sciences of the United States of America. 111: 10299-304. PMID 24982195 DOI: 10.1073/Pnas.1404399111 |
0.524 |
|
| 2014 |
Xu C, Fillmore CM, Koyama S, Wu H, Zhao Y, Chen Z, Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A, Reibel JB, Walton Z, Ji H, Watanabe H, Jänne PA, et al. Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression. Cancer Cell. 25: 590-604. PMID 24794706 DOI: 10.1016/J.Ccr.2014.03.033 |
0.406 |
|
| 2014 |
Lau AN, Curtis SJ, Fillmore CM, Rowbotham SP, Mohseni M, Wagner DE, Beede AM, Montoro DT, Sinkevicius KW, Walton ZE, Barrios J, Weiss DJ, Camargo FD, Wong KK, Kim CF. Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. The Embo Journal. 33: 468-81. PMID 24497554 DOI: 10.1002/Embj.201386082 |
0.522 |
|
| 2014 |
Leeman KT, Fillmore CM, Kim CF. Lung stem and progenitor cells in tissue homeostasis and disease. Current Topics in Developmental Biology. 107: 207-33. PMID 24439808 DOI: 10.1016/B978-0-12-416022-4.00008-1 |
0.508 |
|
| 2012 |
Castaño Z, Fillmore CM, Kim CF, McAllister SS. The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Seminars in Cancer Biology. 22: 462-70. PMID 22548722 DOI: 10.1016/J.Semcancer.2012.04.006 |
0.5 |
|
| 2011 |
Zacharek SJ, Fillmore CM, Lau AN, Gludish DW, Chou A, Ho JW, Zamponi R, Gazit R, Bock C, Jäger N, Smith ZD, Kim TM, Saunders AH, Wong J, Lee JH, et al. Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci. Cell Stem Cell. 9: 272-81. PMID 21885022 DOI: 10.1016/J.Stem.2011.07.007 |
0.459 |
|
| 2011 |
Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, Lander ES. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 146: 633-44. PMID 21854987 DOI: 10.1016/J.Cell.2011.07.026 |
0.482 |
|
| 2010 |
Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, Kuperwasser C. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proceedings of the National Academy of Sciences of the United States of America. 107: 21737-42. PMID 21098263 DOI: 10.1073/Pnas.1007863107 |
0.477 |
|
| 2008 |
Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research : Bcr. 10: R25. PMID 18366788 DOI: 10.1186/Bcr1982 |
0.478 |
|
| 2007 |
Fillmore C, Kuperwasser C. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Research : Bcr. 9: 303. PMID 17540049 DOI: 10.1186/Bcr1673 |
0.47 |
|
| 2005 |
Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proceedings of the National Academy of Sciences of the United States of America. 102: 17745-50. PMID 16301525 DOI: 10.1073/Pnas.0509014102 |
0.384 |
|
| Show low-probability matches. |